SERVAL IS INDICATED :

• In the treatment of depression in adults, including depression associated with symptoms of anxiety. Following a satisfactory therapeutic response, continuing treatment with Serval prevents the occurrence of relapses of depressive episodes.
• In the treatment of obsessive-compulsive disorders in adults and children (aged 6 to 12 years) and adolescents (13-17 years).

SERVAL IS INDICATED :

• In the treatment of depression in adults, including depression associated with symptoms of anxiety. Following a satisfactory therapeutic response, continuing treatment with Serval prevents the occurrence of relapses of depressive episodes.
• In the treatment of obsessive-compulsive disorders in adults and children (aged 6 to 12 years) and adolescents (13-17 years).

TEICO is indicated for parenteral treatment of the following infections in adults and children from birth :

TEICO is indicated for parenteral treatment of the following infections in adults and children from birth :

TEICO is indicated for parenteral treatment of the following infections in adults and children from birth :

TEICO is indicated for parenteral treatment of the following infections in adults and children from birth :

Treatment of major depressive episodes.

For the prevention of recurrence of major depressive episodes.

Treatment of generalized anxiety disorder.

Treatment of social anxiety disorder (social phobia).

Treatment of panic disorder, with or without agoraphobia.

Olanzapine is indicated for the treatment of schizophrenia.

In patients who have initially responded to treatment, olanzapine has demonstrated its effectiveness in maintaining this clinical improvement in the long term.

Olanzapine is indicated for the treatment of moderate to severe manic episodes.

Olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder who have already responded to treatment with olanzapine during a manic episode.

Olanzapine is indicated for the treatment of schizophrenia.

In patients who have initially responded to treatment, olanzapine has demonstrated its effectiveness in maintaining this clinical improvement in the long term.

Olanzapine is indicated for the treatment of moderate to severe manic episodes.

Olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder who have already responded to treatment with olanzapine during a manic episode.

Olanzapine is indicated for the treatment of schizophrenia.

In patients who have initially responded to treatment, olanzapine has demonstrated its effectiveness in maintaining this clinical improvement in the long term.

Olanzapine is indicated for the treatment of moderate to severe manic episodes.

Olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder who have already responded to treatment with olanzapine during a manic episode.